Results 11 to 20 of about 140,818 (295)

Intranasal COVID-19 vaccines: From bench to bed

open access: yesEBioMedicine, 2022
Summary Currently licensed COVID-19 vaccines are all designed for intramuscular (IM) immunization. However, vaccination today failed to prevent the virus infection through the upper respiratory tract, which is partially due to the absence of mucosal ...
Aqu Alu   +5 more
semanticscholar   +1 more source

Intranasal Polymeric and Lipid-Based Nanocarriers for CNS Drug Delivery

open access: yesPharmaceutics, 2023
Nanomedicine is currently focused on the design and development of nanocarriers that enhance drug delivery to the brain to address unmet clinical needs for treating neuropsychiatric disorders and neurological diseases.
R. Maher   +5 more
semanticscholar   +1 more source

Intranasal mRNA-LNP vaccination protects hamsters from SARS-CoV-2 infection

open access: yesbioRxiv, 2023
Intranasal vaccination represents a promising approach for preventing disease caused by respiratory pathogens by eliciting a mucosal immune response in the respiratory tract that may act as an early barrier to infection and transmission.
Gabriela Baldeon Vaca   +19 more
semanticscholar   +1 more source

A Physiologically Based Pharmacokinetic Model for Predicting Diazepam Pharmacokinetics after Intravenous, Oral, Intranasal, and Rectal Applications

open access: yesPharmaceutics, 2021
Diazepam is one of the most prescribed anxiolytic and anticonvulsant that is administered through intravenous (IV), oral, intramuscular, intranasal, and rectal routes.
Sundus Khalid   +9 more
doaj   +1 more source

Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: A current overview of in vivo studies

open access: yesActa Pharmaceutica Sinica B, 2021
The management of the central nervous system (CNS) disorders is challenging, due to the need of drugs to cross the blood‒brain barrier (BBB) and reach the brain. Among the various strategies that have been studied to circumvent this challenge, the use of
C. Costa   +3 more
semanticscholar   +1 more source

Novel Targets and Interventions for Cognitive Complications of Diabetes

open access: yesFrontiers in Physiology, 2022
Diabetes and cognitive dysfunction, ranging from mild cognitive impairment to dementia, often coexist in individuals over 65 years of age. Vascular contributions to cognitive impairment/dementia (VCID) are the second leading cause of dementias under the ...
Victoria Wolf   +5 more
doaj   +1 more source

Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models

open access: yesScience Translational Medicine, 2021
Intranasal vaccination of hamsters and rhesus macaques with ChAdOx1 nCoV-19 reduces shedding of SARS-CoV-2 after challenge. Intranasal SARS-CoV-2 vaccination Protection conferred by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines ...
Neeltje van Doremalen   +20 more
semanticscholar   +1 more source

A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2

open access: yesCell, 2020
The coronavirus disease 2019 pandemic has made deployment of an effective vaccine a global health priority. We evaluated the protective activity of a chimpanzee adenovirus-vectored vaccine encoding a prefusion stabilized spike protein (ChAd-SARS-CoV-2-S)
Ahmed O. Hassan   +30 more
semanticscholar   +1 more source

Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder.

open access: yesNew England Journal of Medicine, 2021
BACKGROUND Experimental studies and small clinical trials have suggested that treatment with intranasal oxytocin may reduce social impairment in persons with autism spectrum disorder.
L. Sikich   +33 more
semanticscholar   +1 more source

Intranasal priming induces local lung-resident B cell populations that secrete protective mucosal antiviral IgA

open access: yesScience immunology, 2021
Description A heterogeneous population of cells secreting mucosal IgA confers protection against influenza virus infection. Flu defense via lung-resident IgA+ memory B cells Secretory IgA antibody is known to be a key effector molecule in establishing ...
Ji-Eun Oh   +9 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy